1 most recent filing and news item mentioning ACRS. Updated every 60 seconds.
EarningsAug 6, 2026Positive
Aclaris Therapeutics announced full Phase 1a trial results for ATI-052 and affirmed timelines for upcoming clinical data readouts and a Phase 2b program.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.